Haemoglobinopathies -- sickle cell disease (SCD) and thalassaemia -- produce musculoskeletal complications through distinct mechanisms that both ultimately impair walking. Sickle cell disease causes vaso-occlusive crises, avascular necrosis (AVN) of the femoral and humeral heads, and chronic pain crises; thalassaemia major produces bone marrow expansion, cortical thinning, pathological fracture risk, and iron-overload-related complications including cardiomyopathy.
Sickle Cell Disease and Walking
The walking limitations in sickle cell disease include:
- Avascular necrosis (AVN) of the femoral head: AVN occurs in approximately 50% of SCD patients by adulthood. It causes progressive hip pain and structural femoral head collapse -- the same mechanism as steroid-induced AVN. This is often the primary walking-limiting complication in adult SCD
- Dactylitis and bone pain during crises: Acute vaso-occlusive crises cause severe bone pain, often in the long bones. During a crisis, weight-bearing is extremely painful
- Stroke: SCD increases stroke risk, particularly in children (24% risk without prophylaxis). Post-stroke hemiplegia follows the standard hemiplegia cane protocol
- Leg ulcers: Chronic lower leg ulcers from sickling reduce walking tolerance
Cane Use in Sickle Cell Disease
- AVN femoral head: Contralateral cane for standard AVN offloading, reducing hip joint contact force by 20-30%. AVN in SCD often affects both hips (bilateral), which may require two canes
- During vaso-occlusive crisis: Pain is too severe for independent walking in many crises -- the cane provides support but hospitalisation and analgesia are the priority
Thalassaemia and Walking
Thalassaemia major (without adequate transfusion) produces bone marrow expansion that weakens cortical bone, causing pathological fractures, vertebral collapse, and growth abnormalities. Well-transfused patients have reduced bone complications but iron overload from transfusions causes cardiac and endocrine complications. Key walking-limiting features:
- Vertebral and long bone fracture risk
- Iron-overload cardiomyopathy limiting exercise capacity
- In chelation-undertreated patients: severe skeletal deformity
Haemoglobinopathy Feature and Cane Role
| Condition | Key Feature | Cane Role |
|---|---|---|
| Sickle cell disease | Bilateral AVN femoral head (up to 50% of adult SCD) | Contralateral cane; may require bilateral canes for bilateral AVN |
| Sickle cell crisis | Acute severe bone pain; may be unable to walk | Cane for support if ambulant; analgesia and hydration are priority |
| Sickle cell stroke | Hemiplegia | As per stroke hemiplegia: cane in unaffected hand |
| Thalassaemia (bone fragility) | Pathological fracture risk; cortical thinning | Cane reduces impact loading on fragile bone; fall prevention |
| Thalassaemia (cardiomyopathy) | Reduced exercise capacity | Cane reduces walking energy demand; pace management |
Related: Walking Cane for AVN of the Hip. Explore DaiWalk walking canes.
